{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:27:18Z","timestamp":1793698038562,"version":"4.5.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and Development Program of Hainan Province","award":["ZDYF2022SHFZ306"],"award-info":[{"award-number":["ZDYF2022SHFZ306"]}]},{"name":"Academic Enhancement Support Program of Hainan Medical University","award":["XSTS2026147"],"award-info":[{"award-number":["XSTS2026147"]}],"id":[{"id":"https:\/\/ror.org\/004eeze55","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"DOI":"10.1007\/s11096-026-02224-x","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:08:10Z","timestamp":1789193290000},"page":"2212-2225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and factors influencing medication adherence after acute myocardial infarction: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Ruolan","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"2224_CR1","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","volume":"86","author":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators","year":"2023","unstructured":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. J Am Coll Cardiol. 2025;86:2167\u2013243. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.015.","journal-title":"J Am Coll Cardiol"},{"key":"2224_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101320","volume":"24","author":"L Lv","year":"2025","unstructured":"Lv L, Skaar JR, Robar C, et al. Clinical, economic, and health care resource utilization burden of acute myocardial infarction and the role of systemic inflammation in US hospitals: a real-world study. Am J Prev Cardiol. 2025;24:101320. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101320.","journal-title":"Am J Prev Cardiol"},{"key":"2224_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.14797\/mdcvj.1393","volume":"20","author":"VD Upadhyaya","year":"2024","unstructured":"Upadhyaya VD, Wong C, Zakir RM, et al. Management of myocardial infarction: emerging paradigms for the future. Methodist Debakey Cardiovasc J. 2024;20:54\u201363. https:\/\/doi.org\/10.14797\/mdcvj.1393.","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2224_CR4","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720\u2013826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191.","journal-title":"Eur Heart J"},{"key":"2224_CR5","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/jcm14072190","volume":"14","author":"A Jabbar","year":"2025","unstructured":"Abdul Jabbar AB, Klisares M, Gilkeson K, et al. Acute myocardial infarction mortality in the older population of the United States: an analysis of demographic and regional trends and disparities from 1999 to 2022. J Clin Med. 2025;14:2190. https:\/\/doi.org\/10.3390\/jcm14072190.","journal-title":"J Clin Med"},{"key":"2224_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68915-1","volume":"10","author":"\u0141 Pietrzykowski","year":"2020","unstructured":"Pietrzykowski \u0141, Michalski P, Kosobucka A, et al. Medication adherence and its determinants in patients after myocardial infarction. Sci Rep. 2020;10:12028. https:\/\/doi.org\/10.1038\/s41598-020-68915-1.","journal-title":"Sci Rep"},{"key":"2224_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jcpt.13348","volume":"46","author":"A Rahhal","year":"2021","unstructured":"Rahhal A, Mahfouz A, Khir F, et al. Medications adherence post-primary percutaneous coronary intervention in acute myocardial infarction: a population-based cohort study. J Clin Pharm Ther. 2021;46:772\u20139. https:\/\/doi.org\/10.1111\/jcpt.13348.","journal-title":"J Clin Pharm Ther"},{"key":"2224_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/ehjqcco\/qcae009","volume":"10","author":"AMD Kristensen","year":"2024","unstructured":"Kristensen AMD, Pareek M, Kragholm KH, et al. Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events. Eur Heart J Qual Care Clin Outcomes. 2024;10:612\u201322. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae009.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2224_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ehjqcco\/qcab024","volume":"8","author":"HT May","year":"2022","unstructured":"May HT, Knowlton KU, Anderson JL, et al. High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study. Eur Heart J Qual Care Clin Outcomes. 2022;8:352\u201360. https:\/\/doi.org\/10.1093\/ehjqcco\/qcab024.","journal-title":"Eur Heart J"},{"key":"2224_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05946-4","volume":"20","author":"F Kirsch","year":"2020","unstructured":"Kirsch F, Becker C, Kurz C, et al. Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs\u2014an analysis of real-world data. BMC Health Serv Res. 2020;20:1145. https:\/\/doi.org\/10.1186\/s12913-020-05946-4.","journal-title":"BMC Health Serv Res"},{"key":"2224_CR11","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2147\/JMDH.S463789","volume":"17","author":"AS Jarab","year":"2024","unstructured":"Jarab AS, Mansour RZ, Muflih S, et al. Determinants of health-related quality of life in outpatients with myocardial infarction. J Multidiscip Healthc. 2024;17:2133\u201345. https:\/\/doi.org\/10.2147\/JMDH.S463789.","journal-title":"J Multidiscip Healthc"},{"key":"2224_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86:304\u201314. https:\/\/doi.org\/10.4065\/mcp.2010.0575.","journal-title":"Mayo Clin Proc"},{"key":"2224_CR13","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s11096-025-01927-x","volume":"47","author":"F El-Komy","year":"2025","unstructured":"El-Komy F, Sahm LJ, Byrne S, et al. Barriers and facilitators to managing medicines at home post-myocardial infarction: a qualitative systematic review. Int J Clin Pharm. 2025;47:1549\u201366. https:\/\/doi.org\/10.1007\/s11096-025-01927-x.","journal-title":"Int J Clin Pharm"},{"key":"2224_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.clinthera.2023.08.011","volume":"45","author":"M Bahit","year":"2023","unstructured":"Bahit M, Korjian S, Daaboul Y, et al. Patient adherence to secondary prevention therapies after an acute coronary syndrome: a scoping review. Clin Ther. 2023;45:1119\u201326. https:\/\/doi.org\/10.1016\/j.clinthera.2023.08.011.","journal-title":"Clin Ther"},{"key":"2224_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.hrtlng.2015.02.004","volume":"44","author":"H-Y Chen","year":"2015","unstructured":"Chen H-Y, Saczynski JS, Lapane KL, et al. Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: a systematic review. Heart Lung. 2015;44:299\u2013308. https:\/\/doi.org\/10.1016\/j.hrtlng.2015.02.004.","journal-title":"Heart Lung"},{"key":"2224_CR16","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1093\/pubmed\/fdy088","volume":"41","author":"KH Leslie","year":"2019","unstructured":"Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Public Health. 2019;41:e84-94. https:\/\/doi.org\/10.1093\/pubmed\/fdy088.","journal-title":"J Public Health"},{"key":"2224_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2147\/PPA.S356653","volume":"16","author":"O Zorina","year":"2022","unstructured":"Zorina O, Fatkulina N, Saduyeva F, et al. Patient adherence to therapy after myocardial infarction: a scoping review. Patient Prefer Adherence. 2022;16:1613\u201322. https:\/\/doi.org\/10.2147\/PPA.S356653.","journal-title":"Patient Prefer Adherence"},{"key":"2224_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"2224_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.11124\/JBIES-24-00103","volume":"23","author":"TH Barker","year":"2025","unstructured":"Barker TH, Hasanoff S, Aromataris E, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies. JBI Evid Synth. 2025;23:441\u201353. https:\/\/doi.org\/10.11124\/JBIES-24-00103.","journal-title":"JBI Evid Synth"},{"key":"2224_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0324072","volume":"20","author":"AM Nordenskj\u00f6ld","year":"2025","unstructured":"Nordenskj\u00f6ld AM, Qvarnstr\u00f6m M, Wettermark B, et al. Adherence to secondary preventive treatment following myocardial infarction with and without obstructive coronary artery disease. PLoS ONE. 2025;20:e0324072. https:\/\/doi.org\/10.1371\/journal.pone.0324072.","journal-title":"PLoS ONE"},{"key":"2224_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.834898","volume":"13","author":"A Campain","year":"2022","unstructured":"Campain A, Hockham C, Sukkar L, et al. Prior cardiovascular treatments\u2014a key characteristic in determining medication adherence after an acute myocardial infarction. Front Pharmacol. 2022;13:834898. https:\/\/doi.org\/10.3389\/fphar.2022.834898.","journal-title":"Front Pharmacol"},{"key":"2224_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-01969-9","volume":"21","author":"M Di Martino","year":"2021","unstructured":"Di Martino M, Alagna M, Lallo A, et al. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication. BMC Cardiovasc Disord. 2021;21:180. https:\/\/doi.org\/10.1186\/s12872-021-01969-9.","journal-title":"BMC Cardiovasc Disord"},{"key":"2224_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042878","volume":"11","author":"S Soldati","year":"2021","unstructured":"Soldati S, Di Martino M, Castagno D, et al. In-hospital myocardial infarction and adherence to evidence-based drug therapies: a real-world evaluation. BMJ Open. 2021;11:e042878. https:\/\/doi.org\/10.1136\/bmjopen-2020-042878.","journal-title":"BMJ Open"},{"key":"2224_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.016215","volume":"10","author":"JA Rymer","year":"2021","unstructured":"Rymer JA, Fonseca E, Bhandary DD, et al. Difference in medication adherence between patients prescribed a 30-day versus 90-day supply after acute myocardial infarction. J Am Heart Assoc. 2021;10:e016215. https:\/\/doi.org\/10.1161\/JAHA.119.016215.","journal-title":"J Am Heart Assoc"},{"key":"2224_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jac5.1369","volume":"4","author":"A Rahhal","year":"2021","unstructured":"Rahhal A, Mahfouz A, Al-Amri M, et al. Impact of discharge education by clinical pharmacists on patients\u2019 adherence to post-percutaneous coronary intervention medications: a retrospective cohort study using real-world data. JACCP J Am Coll Clin Pharm. 2021;4:303\u201310. https:\/\/doi.org\/10.1002\/jac5.1369.","journal-title":"JACCP J Am Coll Clin Pharm"},{"key":"2224_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ehf2.13079","volume":"8","author":"L Desta","year":"2021","unstructured":"Desta L, Khedri M, Jernberg T, et al. Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarction. ESC Heart Fail. 2021;8:344\u201355. https:\/\/doi.org\/10.1002\/ehf2.13079.","journal-title":"ESC Heart Fail"},{"key":"2224_CR27","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/jgs.16037","volume":"67","author":"DQ Phan","year":"2019","unstructured":"Phan DQ, Duan L, Lam B, et al. Statin adherence and mortality in patients aged 80\u2009years and older after acute myocardial infarction. J Am Geriatr Soc. 2019;67:2045\u20139. https:\/\/doi.org\/10.1111\/jgs.16037.","journal-title":"J Am Geriatr Soc"},{"key":"2224_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/2047487317693951","volume":"24","author":"J Wallert","year":"2017","unstructured":"Wallert J, Lissaker C, Madison G, et al. Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: a Swedish National Registry study. Eur J Prev Cardiol. 2017;24:639\u201346. https:\/\/doi.org\/10.1177\/2047487317693951.","journal-title":"Eur J Prev Cardiol"},{"key":"2224_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamacardio.2017.0911","volume":"2","author":"LD Colantonio","year":"2017","unstructured":"Colantonio LD, Huang L, Monda KL, et al. Adherence to high-intensity statins following a myocardial infarction hospitalization among Medicare beneficiaries. JAMA Cardiol. 2017;2:890\u20135. https:\/\/doi.org\/10.1001\/jamacardio.2017.0911.","journal-title":"JAMA Cardiol"},{"key":"2224_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1177\/2047487315597209","volume":"23","author":"H Hamood","year":"2016","unstructured":"Hamood H, Hamood R, Green MS, et al. Determinants of adherence to evidence-based therapy after acute myocardial infarction. Eur J Prev Cardiol. 2016;23:975\u201385. https:\/\/doi.org\/10.1177\/2047487315597209.","journal-title":"Eur J Prev Cardiol"},{"key":"2224_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2261-11-56","volume":"11","author":"EJ Lai","year":"2011","unstructured":"Lai EJ, Grubisic M, Palepu A, et al. Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients. BMC Cardiovasc Disord. 2011;11:56. https:\/\/doi.org\/10.1186\/1471-2261-11-56.","journal-title":"BMC Cardiovasc Disord"},{"key":"2224_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010926","volume":"6","author":"M Di Martino","year":"2016","unstructured":"Di Martino M, Alagna M, Cappai G, et al. Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design. BMJ Open. 2016;6:e010926. https:\/\/doi.org\/10.1136\/bmjopen-2015-010926.","journal-title":"BMJ Open"},{"key":"2224_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jamacardio.2016.0001","volume":"1","author":"KF Faridi","year":"2016","unstructured":"Faridi KF, Peterson ED, McCoy LA, et al. Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction. JAMA Cardiol. 2016;1:147\u201355. https:\/\/doi.org\/10.1001\/jamacardio.2016.0001.","journal-title":"JAMA Cardiol"},{"key":"2224_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamacardio.2016.2724","volume":"1","author":"JA Doll","year":"2016","unstructured":"Doll JA, Hellkamp AS, Goyal A, et al. Treatment, outcomes, and adherence to medication regimens among dual Medicare-Medicaid\u2013eligible adults with myocardial infarction. JAMA Cardiol. 2016;1:787\u201394. https:\/\/doi.org\/10.1001\/jamacardio.2016.2724.","journal-title":"JAMA Cardiol"},{"key":"2224_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CEOR.S70936","volume":"7","author":"B Monaldi","year":"2015","unstructured":"Monaldi B, Bologna G, Costa GG, et al. Adherence to statin treatment following a myocardial infarction: an Italian population-based survey. Clinicoecon Outcomes Res. 2015;7:273\u201380. https:\/\/doi.org\/10.2147\/CEOR.S70936.","journal-title":"Clin Outcomes Res"},{"key":"2224_CR36","doi-asserted-by":"publisher","unstructured":"Basios A, Markozannes G, Ntzani EE, et al. Prevalence and determinants of adherence to statin therapy: a systematic review and meta-analysis. Eur J Prev Cardiol 2025;zwaf769. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf769.","DOI":"10.1093\/eurjpc\/zwaf769"},{"key":"2224_CR37","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/PPA.S260562","volume":"14","author":"M Vervloet","year":"2020","unstructured":"Vervloet M, Korevaar JC, Leemrijse CJ, et al. Interventions to improve adherence to cardiovascular medication: what about gender differences? A systematic literature review. Patient Prefer Adherence. 2020;14:2055\u201370. https:\/\/doi.org\/10.2147\/PPA.S260562.","journal-title":"Patient Prefer Adherence"},{"key":"2224_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pmedr.2017.02.010","volume":"6","author":"DE Jarb\u00f8l","year":"2017","unstructured":"Jarb\u00f8l DE, Larsen PV, Gyrd-Hansen D, et al. Determinants of preferences for lifestyle changes versus medication and beliefs in ability to maintain lifestyle changes. A population-based survey. Prev Med Rep. 2017;6:66\u201373. https:\/\/doi.org\/10.1016\/j.pmedr.2017.02.010.","journal-title":"Prev Med Rep"},{"key":"2224_CR39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40266-025-01249-7","volume":"42","author":"EAR Stanly","year":"2025","unstructured":"Stanly EAR, Vilakkathala R, George J. Medication non-adherence in older adults: underlying factors, potential interventions and outcomes. Drugs Aging. 2025;42:991\u20131000. https:\/\/doi.org\/10.1007\/s40266-025-01249-7.","journal-title":"Drugs Aging"},{"key":"2224_CR40","doi-asserted-by":"publisher","DOI":"10.2196\/17883","volume":"22","author":"SM Badawy","year":"2020","unstructured":"Badawy SM, Shah R, Beg U, et al. Habit strength, medication adherence, and habit-based mobile health interventions across chronic medical conditions: systematic review. J Med Internet Res. 2020;22:e17883. https:\/\/doi.org\/10.2196\/17883.","journal-title":"J Med Internet Res"},{"key":"2224_CR41","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.4187\/respcare.07355","volume":"65","author":"B Bhattarai","year":"2020","unstructured":"Bhattarai B, Walpola R, Mey A, et al. Barriers and strategies for improving medication adherence among people living with COPD: a systematic review. Respir Care. 2020;65:1738\u201350. https:\/\/doi.org\/10.4187\/respcare.07355.","journal-title":"Respir Care"},{"key":"2224_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029862","volume":"9","author":"SJ Kim","year":"2019","unstructured":"Kim SJ, Kwon OD, Cho B, et al. Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean nationwide study. BMJ Open. 2019;9:e029862. https:\/\/doi.org\/10.1136\/bmjopen-2019-029862.","journal-title":"BMJ Open"},{"key":"2224_CR43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMoa2208275","volume":"387","author":"JM Castellano","year":"2022","unstructured":"Castellano JM, Pocock SJ, Bhatt DL, et al. Polypill strategy in secondary cardiovascular prevention. N Engl J Med. 2022;387:967\u201377. https:\/\/doi.org\/10.1056\/NEJMoa2208275.","journal-title":"N Engl J Med"},{"key":"2224_CR44","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18527","volume":"12","author":"J Zeng","year":"2024","unstructured":"Zeng J, Gao Y, Hou C, et al. The impact of doctor\u2013patient communication on medication adherence and blood pressure control in patients with hypertension: a systematic review. PeerJ. 2024;12:e18527. https:\/\/doi.org\/10.7717\/peerj.18527.","journal-title":"PeerJ"},{"key":"2224_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.041781","volume":"14","author":"J Ohm","year":"2025","unstructured":"Ohm J, Ma K, Freyland S, et al. Income-level and immigrant status are associated with discontinuation of evidence-based secondary prevention therapies after myocardial infarction. J Am Heart Assoc. 2025;14:e041781. https:\/\/doi.org\/10.1161\/JAHA.124.041781.","journal-title":"J Am Heart Assoc"},{"key":"2224_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s43094-024-00738-7","volume":"10","author":"M Nicola","year":"2024","unstructured":"Nicola M, Nicola M, Zarif B, et al. Prevalence of anxiety and depression and the influence of correlates in acute coronary syndrome patients: a cross-sectional analysis. Futur J Pharm Sci. 2024;10:155. https:\/\/doi.org\/10.1186\/s43094-024-00738-7.","journal-title":"Future J Pharm Sci"},{"key":"2224_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-024-01959-4","volume":"12","author":"AM Ashour","year":"2024","unstructured":"Ashour AM, Masa\u2019deh R, Hamaideh SH, et al. Examining the influence of anxiety and depression on medication adherence among patients diagnosed with acute myocardial infarction. BMC Psychol. 2024;12:473. https:\/\/doi.org\/10.1186\/s40359-024-01959-4.","journal-title":"BMC Psychol"},{"key":"2224_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05129-1","volume":"25","author":"C Swoboda","year":"2025","unstructured":"Swoboda C, Gellert P, Steinhagen-Thiessen E, et al. Depression, anxiety, posttraumatic stress disorder and perceived psychosocial care during hospital stay after myocardial infarction: a cross-sectional study. BMC Cardiovasc Disord. 2025;25:650. https:\/\/doi.org\/10.1186\/s12872-025-05129-1.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02224-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:39:31Z","timestamp":1793695171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02224-x","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}